Emily Hussey

Emily leverages more than a decade of experience in healthcare and life sciences law to provide strategic business and regulatory advice to a diverse range of clients. She is passionate about helping healthcare platforms, drug distributors, pharmacies, hospital systems, and outsourcing facilities, among others, navigate the complex and evolving Food and Drug Administration (“FDA”), Drug Enforcement Administration, and state regulations that govern their operations and transactions.

Emily’s extensive experience in life sciences and healthcare transactions includes assisting clients with mergers and acquisitions. She advises on due diligence, change of ownership, regulatory approvals, and related issues in connection with these transactions. Her goal is to help clients achieve their business objectives while ensuring compliance and quality in healthcare services.

Emily also has a deep understanding of life sciences-related issues, with a particular focus on the regulation of compounded drugs across both the human and animal health spheres. She is a recognized industry advocate and thought leader who actively engages with regulators, legislators, and stakeholders to advance the interests of companies in the life sciences, including compounding pharmacies and outsourcing facilities.